In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sagimet Biosciences Inc (NASDAQ: SGMT) closed the day trading at $4.73 down -8.69% from the previous closing price of $5.18. In other words, the price has decreased by -$8.69 from its previous closing price. On the day, 0.84 million shares were traded. SGMT stock price reached its highest trading level at $5.18 during the session, while it also had its lowest trading level at $4.58.
Ratios:
For a better understanding of SGMT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 38.34 and its Current Ratio is at 38.34. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on November 12, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On June 28, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $6.
On May 02, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $32.H.C. Wainwright initiated its Buy rating on May 02, 2024, with a $32 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 23 ’24 when Kemble George sold 23,625 shares for $3.17 per share. The transaction valued at 74,830 led to the insider holds 118,693 shares of the business.
Martins Eduardo Bruno sold 8,357 shares of SGMT for $25,910 on Jul 19 ’24. The Chief Medical Officer now owns 81,213 shares after completing the transaction at $3.10 per share. On Jul 19 ’24, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,914 shares for $3.10 each. As a result, the insider received 33,830 and left with 160,506 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 152283776 and an Enterprise Value of -906065. Its current Enterprise Value per Revenue stands at -0.453.
Stock Price History:
Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.25. The 50-Day Moving Average of the stock is 4.54%, while the 200-Day Moving Average is calculated to be 4.65%.
Shares Statistics:
Over the past 3-months, SGMT traded about 1.43M shares per day on average, while over the past 10 days, SGMT traded about 798900 shares per day. A total of 21.38M shares are outstanding, with a floating share count of 20.41M. Insiders hold about 34.36% of the company’s shares, while institutions hold 47.22% stake in the company. Shares short for SGMT as of 1730332800 were 4171230 with a Short Ratio of 2.92, compared to 1727654400 on 1971420. Therefore, it implies a Short% of Shares Outstanding of 4171230 and a Short% of Float of 15.479999999999999.
